Dubuque Bank & Trust’s Pfizer PFE Stock Holding History

Dubuque Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.07M	Buy	32,266 +1,778	+6%	+$62.9K	0.14%	83
2023 Q2	$1.12M	Sell	30,488 -155	-0.5%	-$6.03K	0.14%	82
2023 Q1	$1.25M	Sell	30,643 -1,355	-4%	-$58.5K	0.16%	82
2022 Q4	$1.64M	Sell	31,998 -2,316	-7%	-$111K	0.21%	79
2022 Q3	$1.5M	Sell	34,314 -942	-3%	-$45.8K	0.21%	81
2022 Q2	$1.85M	Sell	35,256 -317	-0.9%	-$16.2K	0.24%	79
2022 Q1	$1.84M	Sell	35,573 -74	-0.2%	-$3.84K	0.21%	79
2021 Q4	$2.1M	Sell	35,647 -2,085	-6%	-$103K	0.22%	76
2021 Q3	$1.62M	Sell	37,732 -2,297	-6%	-$102K	0.18%	82
2021 Q2	$1.57M	Sell	40,029 -9,844	-20%	-$383K	0.17%	87
2021 Q1	$1.81M	Sell	49,873 -236	-0.5%	-$8.38K	0.21%	80
2020 Q4	$1.84M	Buy	50,109 +11,748	+31%	+$431K	0.23%	75
2020 Q3	$1.34M	Sell	38,361 -11,835	-24%	-$415K	0.2%	90
2020 Q2	$1.56M	Buy	50,196 +2,391	+5%	+$81.2K	0.24%	78
2020 Q1	$1.48M	Buy	47,805 +1,840	+4%	+$62.7K	0.28%	74
2019 Q4	$1.71M	Buy	45,965 +598	+1%	+$21.3K	0.26%	77
2019 Q3	$1.55M	Buy	45,367 +290	+0.6%	+$10.5K	0.25%	75
2019 Q2	$1.85M	Sell	45,077 -1,483	-3%	-$58.9K	0.3%	72
2019 Q1	$1.88M	Buy	46,560 +2,119	+5%	+$84.9K	0.3%	70
2018 Q4	$1.84M	Hold	44,441	–	–	0.33%	67
2018 Q3	$1.86M	Sell	44,441 -105	-0.2%	-$4.04K	0.29%	64
2018 Q2	$1.53M	Sell	44,546 -3,547	-7%	-$121K	0.25%	69
2018 Q1	$1.62M	Buy	48,093 +177	+0.4%	+$6.08K	0.26%	71
2017 Q4	$1.65M	Buy	47,916 +2,425	+5%	+$82.7K	0.25%	73
2017 Q3	$1.54M	Buy	45,491 +11,726	+35%	+$377K	0.25%	71
2017 Q2	$1.08M	Sell	33,765 -6,292	-16%	-$198K	0.23%	78
2017 Q1	$1.3M	Buy	40,057 +809	+2%	+$25.5K	0.29%	77
2016 Q4	$1.21M	Buy	39,248 +2,101	+6%	+$64.1K	0.21%	78
2016 Q3	$1.19M	Sell	37,147 -1,377	-4%	-$46K	0.22%	80
2016 Q2	$1.29M	Buy	38,524 +725	+2%	+$23.1K	0.25%	80
2016 Q1	$1.06M	Sell	37,799 -44,419	-54%	-$1.27M	0.21%	94
2015 Q4	$2.52M	Sell	82,218 -829	-1%	-$26.1K	0.53%	60
2015 Q3	$2.48M	Buy	83,047 +2,370	+3%	+$76K	0.53%	57
2015 Q2	$2.57M	Buy	80,677 +43,637	+118%	+$1.42M	0.48%	58
2015 Q1	$1.22M	Buy	37,040 +114	+0.3%	+$3.62K	0.18%	102
2014 Q4	$1.09M	Buy	36,926 +4,804	+15%	+$138K	0.17%	72
2014 Q3	$901K	Sell	32,122 -5,159	-14%	-$145K	0.15%	73
2014 Q2	$1.05M	Buy	37,281 +15,062	+68%	+$429K	0.17%	76
2014 Q1	$677K	Buy	22,219 +1,320	+6%	+$39.4K	0.12%	82
2013 Q4	$607K	Buy	20,899 +1,602	+8%	+$46.6K	0.11%	84
2013 Q3	$526K	Buy	19,297 +1,692	+10%	+$46K	0.1%	86
2013 Q2	$468K	Buy	+17,605	New	+$486K	0.09%	81

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dubuque Bank & Trust's PFE Position: Q3 2023 in Review

Dubuque Bank & Trust increased its Pfizer (PFE) stake by 5.8% in Q3 2023, buying an estimated $62.9K and bringing the position to 32,266 shares worth $1.07M. The position accounts for 0.14% of the portfolio, ranked #83.

Dubuque Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.57M in Q2 2015. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Dubuque Bank & Trust held 32,266 shares of Pfizer worth $1.07M as of Q3 2023.
Dubuque Bank & Trust bought 1,778 Pfizer shares in Q3 2023, an estimated $62.9K.
Pfizer made up 0.14% of Dubuque Bank & Trust's portfolio in Q3 2023, its #83 holding.
Dubuque Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 42 quarters since.
Dubuque Bank & Trust's Pfizer position peaked at $2.57M in Q2 2015.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Dubuque Bank & Trust's 13F filing for Q3 2023, filed 27 Oct 2023.